DarioHealth Corp Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $21M-22.3% YoYTTM through 30 Jun 2026
Net Income -$35.7MTTM through 30 Jun 2026
Free Cash Flow -$25.5MTTM through 30 Jun 2026
Margins
| Current | |
|---|---|
| Gross Margin | 56.6% |
| EBITDA Margin | -139.8% |
| Operating Margin | -163.9% |
| Net Margin | -169.9% |
Returns
-66.8%ROE
-37.9%ROA
Balance Sheet Health
Debt / Equity0.50x
Current Ratio2.31x
Net Debt$4.9M
Cash & Equivalents$6.6M
Quality Metrics
Altman Z-Score-6.53
Piotroski F-Score3 / 9
FCF Margin-121.3%
Rule of 40-118.2
Earnings-Beat Rate50.0%
Multi-Year Trend
RevenueFY2025: $22.4M
Diluted EPS-$5.37TTMFY2025: $10.12
Dividend
No dividend
Capital Allocation
R&D Spend$10.4M
Capex Intensity0.6%
Segment Performance
| Segment | Revenue | YoY | Outlook |
|---|---|---|---|
| Services | $14.9M | -26.1% | |
| Consumer hardware | $7.4M | +8.6% |
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.